All companies › ONC

ONC · BeOne Medicines Ltd.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells16
Research cases0
Last filing2026-10-13

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-28 — Wang Xiaodong · sold 120 @ $358.71 2026-09-28 — Wang Xiaodong · sold 14,525 @ $366.58 2026-09-28 — Wang Xiaodong · sold 160 @ $356.97 2026-09-28 — Wang Xiaodong · sold 2,047 @ $365.85 2026-09-28 — Wang Xiaodong · sold 2,241 @ $361.05 2026-09-28 — Wang Xiaodong · sold 3,419 @ $364.07 2026-09-28 — Wang Xiaodong · sold 3,499 @ $363.10 2026-09-28 — Wang Xiaodong · sold 40 @ $359.16 2026-09-28 — Wang Xiaodong · sold 4,239 @ $362.17 2026-09-28 — Wang Xiaodong · sold 738 @ $367.23 2026-09-30 — Lee Chan Henry · sold 1,115 @ $375.00 2026-10-13 — Wang Xiaodong · sold 7,167 @ $349.56 2026-10-13 — Wang Xiaodong · sold 10,361 @ $350.47 2026-10-13 — Wang Xiaodong · sold 5,681 @ $351.40 2026-10-13 — Wang Xiaodong · sold 6,558 @ $352.57 2026-10-13 — Wang Xiaodong · sold 1,260 @ $353.24
2026-09-282026-10-13

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Wang Xiaodong Director, Other
Lee Chan Henry SVP, General Counsel
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $ONC is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-13', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Chair, Scientific Advisory Brd', 'transaction_type': 'Open-market sell', 'shares': 7167.0, 'price': 349.5613, 'value': 2505305.84, 'is_buy': False}, {'transaction_date': '2026-10-13', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Chair, Scientific Advisory Brd', 'transaction_type': 'Open-market sell', 'shares': 10361.0, 'price': 350.4741, 'value': 3631262.15, 'is_buy': False}, {'transaction_date': '2026-10-13', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Chair, Scientific Advisory Brd', 'transaction_type': 'Open-market sell', 'shares': 5681.0, 'price': 351.3958, 'value': 1996279.54, 'is_buy': False}, {'transaction_date': '2026-10-13', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Chair, Scientific Advisory Brd', 'transaction_type': 'Open-market sell', 'shares': 6558.0, 'price': 352.5691, 'value': 2312148.16, 'is_buy': False}, {'transaction_date': '2026-10-13', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Chair, Scientific Advisory Brd', 'transaction_type': 'Open-market sell', 'shares': 1260.0, 'price': 353.2367, 'value': 445078.24, 'is_buy': False}, {'transaction_date': '2026-09-30', 'insider_name': 'Lee Chan Henry', 'insider_title': 'SVP, General Counsel', 'transaction_type': 'Open-market sell', 'shares': 1115.0, 'price': 375.0, 'value': 418125.0, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 120.0, 'price': 358.71, 'value': 43045.2, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 14525.0, 'price': 366.58, 'value': 5324574.5, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 160.0, 'price': 356.97, 'value': 57115.2, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 2047.0, 'price': 365.85, 'value': 748894.95, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 2241.0, 'price': 361.05, 'value': 809113.05, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 3419.0, 'price': 364.07, 'value': 1244755.33, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 3499.0, 'price': 363.1, 'value': 1270486.9, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 40.0, 'price': 359.16, 'value': 14366.4, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 4239.0, 'price': 362.17, 'value': 1535238.63, 'is_buy': False}, {'transaction_date': '2026-09-28', 'insider_name': 'Wang Xiaodong', 'insider_title': 'Director, Other', 'transaction_type': 'Open-market sell', 'shares': 738.0, 'price': 367.23, 'value': 271015.74, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for ONC today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.